Save

Cannabis Reform, ‘Medical and Scientific Purposes’ and the Vienna Convention on the Law of Treaties

In: International Community Law Review
View More View Less
  • 1 Associate Professor of Criminology and Human Rights, Hillary Rodham Clinton School of Law, Swansea University
  • | 2 Co-Director, International Centre on Human Rights and Drug Policy, Human Rights Centre, University of Essex; Jur.Dr., Department of Law, Stockholm University
Download Citation Get Permissions

Access options

Get access to the full article by using one of the access options below.

Institutional Login

Log in with Open Athens, Shibboleth, or your institutional credentials

Login via Institution

Purchase

Buy instant access (PDF download and unlimited online access):

€29.95$34.95

Abstract

Treaty interpretation has long been a subject of interest for international legal scholars. However, it is only recently that advocates for drug policy reform have taken up these questions. This article examines the proposition put forward by several authors that a legally regulated market in cannabis may be permissible under the international drug control treaties if considered as a policy ‘experiment’. These authors contend that such measures conform to the general obligation of the Single Convention on Narcotic Drugs to limit uses of cannabis ‘strictly to medical and scientific purposes’. Reviewing this position using the formal methods set out in Articles 31 and 32 of the Vienna Convention on the Law of Treaties, we conclude the interpretation proposed is untenable. While we share with these authors the objective of wider drug policy reform, we find the arguments supporting this position weak, and based on absent, flawed or incomplete interpretive methodology.

Content Metrics

All Time Past Year Past 30 Days
Abstract Views 795 165 12
Full Text Views 219 16 0
PDF Views & Downloads 114 42 0